Cogent Biosciences, Inc. (COGT)
30.38
-0.49
(-1.59%)
USD |
NASDAQ |
Oct 06, 16:00
30.94
+0.56
(+1.84%)
After-Hours: 07:09
Cogent Biosciences Max Drawdown (5Y) : 94.16% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.16% |
| August 31, 2026 | 94.16% |
| July 31, 2026 | 94.16% |
| June 30, 2026 | 94.16% |
| May 31, 2026 | 94.16% |
| April 30, 2026 | 94.16% |
| March 31, 2026 | 94.16% |
| February 28, 2026 | 94.16% |
| January 31, 2026 | 94.16% |
| December 31, 2025 | 94.16% |
| November 30, 2025 | 94.16% |
| October 31, 2025 | 94.16% |
| September 30, 2025 | 94.16% |
| August 31, 2025 | 94.16% |
| July 31, 2025 | 94.16% |
| June 30, 2025 | 97.35% |
| May 31, 2025 | 97.41% |
| April 30, 2025 | 97.67% |
| March 31, 2025 | 98.09% |
| February 28, 2025 | 98.09% |
| January 31, 2025 | 98.09% |
| December 31, 2024 | 98.09% |
| November 30, 2024 | 98.09% |
| October 31, 2024 | 98.09% |
| September 30, 2024 | 98.09% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.09% |
| July 31, 2024 | 98.09% |
| June 30, 2024 | 98.09% |
| May 31, 2024 | 98.09% |
| April 30, 2024 | 98.09% |
| March 31, 2024 | 98.09% |
| February 29, 2024 | 98.09% |
| January 31, 2024 | 98.09% |
| December 31, 2023 | 98.09% |
| November 30, 2023 | 98.09% |
| October 31, 2023 | 98.09% |
| September 30, 2023 | 98.09% |
| August 31, 2023 | 98.09% |
| July 31, 2023 | 98.09% |
| June 30, 2023 | 98.09% |
| May 31, 2023 | 98.09% |
| April 30, 2023 | 98.09% |
| March 31, 2023 | 98.09% |
| February 28, 2023 | 98.09% |
| January 31, 2023 | 98.09% |
| December 31, 2022 | 98.09% |
| November 30, 2022 | 98.09% |
| October 31, 2022 | 98.09% |
| September 30, 2022 | 98.09% |
| August 31, 2022 | 98.09% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Moderna, Inc. | 95.38% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 23.72 |
| Beta (5Y) | 0.3148 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 103.8% |
| Historical Sharpe Ratio (5Y) | 0.259 |
| Historical Sortino (5Y) | 0.7426 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.67% |